Blue Harbour Group’s Medpace MEDP Stock Holding History

Blue Harbour Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-725,500	Closed	-$47.5M	–	15
2019 Q2	$47.5M	Buy	+725,500	New	+$41.8M	2.78%	10

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Blue Harbour Group's MEDP Position: Q3 2019 in Review

Blue Harbour Group sold out of Medpace (MEDP) in Q3 2019, closing a stake of 725,500 shares — an estimated $47.5M sold.

Blue Harbour Group first reported a position in MEDP in Q2 2019 and held it in 1 quarter. The position peaked at $47.5M in Q2 2019. 268 funds tracked by Wall St. Rank hold MEDP as of Q3 2019.

Blue Harbour Group reported no remaining Medpace position as of Q3 2019 after selling out during the quarter.
Blue Harbour Group sold 725,500 Medpace shares in Q3 2019, an estimated $47.5M.
Blue Harbour Group first reported a position in Medpace in Q2 2019 and held it in 1 quarter.
Blue Harbour Group's Medpace position peaked at $47.5M in Q2 2019.
268 funds tracked by Wall St. Rank held Medpace as of Q3 2019.

Based on Blue Harbour Group's 13F filing for Q3 2019, filed 14 Nov 2019.